Exposure to cigarettes and e-cigarettes: changes in the expression of inflammatory and SARS-CoV-2 viral entry genes
Year: 2026
Type: article
Abstract: Introduction As of 2026, 11% of the UK adult population smoke tobacco cigarettes and 10% vape e-cigarettes. For pandemic preparedness, it is essential to identify populations that may be at a higher risk of infection to ensure more targeted public health advice. Any association between smoking and SARS-CoV-2 infection remains conflicted and there is limited research on the impact of vaping. Methods A human bronchial epithelial cell line cultured at the air-liquid interface was exposed, via suspension, to e-liquid, e-cigarette condensate or tobacco cigarette condensate to determine any direct impacts on respiratory toxicity or genes relating to viral entry and/or inflammation. Results Results demonstrate that e-cigarette condensate had minimal toxicity compared to tobacco cigarette condensate. Additionally, gene expression changes in-vitro suggest exposure to tobacco cigarette condensate increases infection risk compared to e-cigarette condensate exposure. Conclusion Preliminary investigations with SARS-CoV-2 infection reiterates the differing effects of e-cigarette and tobacco cigarette condensate exposure, highlighting the importance of further investigations in both areas to inform public health advice.
Source: Frontiers in Immunology
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7225998040
